Old Web
English
Sign In
Acemap
>
authorDetail
>
Benjamin Krantz
Benjamin Krantz
Columbia University Medical Center
Capecitabine
Regimen
Temozolomide
Neuroendocrine tumors
Medicine
3
Papers
182
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
2013
Cancer Chemotherapy and Pharmacology
Robert L. Fine
Anthony Paul Gulati
Benjamin Krantz
Rebecca A. Moss
Stephen M. Schreibman
Dawn Tsushima
Kelley B. Mowatt
Richard D. Dinnen
Yuehua Mao
Peter D. Stevens
Beth Schrope
John D. Allendorf
James A. Lee
William Sherman
John A. Chabot
Show All
Source
Cite
Save
Citations (170)
The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after failure of previous therapy: Columbia University Medical Center experience.
2013
Journal of Clinical Oncology
Paul E. Oberstein
Anthony Paul Gulati
Benjamin Krantz
Rebecca A. Moss
Stephen M. Schreibman
Dawn Tsushima
Kelley B. Mowatt
John D. Allendorf
Beth Schrope
James A. Lee
William H. Sherman
John A. Chabot
Robert L. Fine
Show All
Source
Cite
Save
Citations (1)
Treatment of Multiple Endocrine Neoplasia 1/2 Tumors: Case Report and Review of the Literature
2013
Oncology
Anthony Paul Gulati
Benjamin Krantz
Rebecca A. Moss
Wendy N. Moyal
Dawn Tsushima
Kelley B. Mowatt
Stephen M. Schreibman
Robert L. Fine
Show All
Source
Cite
Save
Citations (11)
1